FI901103A0 - Menetelmä N-substituoitujen aminoalkaanidifosfonihappojen valmistamiseksi - Google Patents
Menetelmä N-substituoitujen aminoalkaanidifosfonihappojen valmistamiseksiInfo
- Publication number
- FI901103A0 FI901103A0 FI901103A FI901103A FI901103A0 FI 901103 A0 FI901103 A0 FI 901103A0 FI 901103 A FI901103 A FI 901103A FI 901103 A FI901103 A FI 901103A FI 901103 A0 FI901103 A0 FI 901103A0
- Authority
- FI
- Finland
- Prior art keywords
- substituted
- preparation
- formula
- image
- metabolism
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 101100490437 Mus musculus Acvrl1 gene Proteins 0.000 abstract 1
- 230000003913 calcium metabolism Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 125000001841 imino group Chemical group [H]N=* 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 abstract 1
- 230000000865 phosphorylative effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000004149 thio group Chemical group *S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH86689 | 1989-03-08 | ||
| CH86689 | 1989-03-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI901103A0 true FI901103A0 (fi) | 1990-03-05 |
| FI95264B FI95264B (fi) | 1995-09-29 |
| FI95264C FI95264C (fi) | 1996-01-10 |
Family
ID=4197009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI901103A FI95264C (fi) | 1989-03-08 | 1990-03-05 | Menetelmä N-substituoitujen aminoalkaanidifosfonihappojen valmistamiseksi |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5036058A (fi) |
| EP (1) | EP0387194B1 (fi) |
| JP (1) | JPH02279689A (fi) |
| KR (1) | KR900014413A (fi) |
| AT (1) | ATE117308T1 (fi) |
| AU (1) | AU629298B2 (fi) |
| CA (1) | CA2011586A1 (fi) |
| DD (1) | DD297824A5 (fi) |
| DE (1) | DE59008275D1 (fi) |
| DK (1) | DK0387194T3 (fi) |
| ES (1) | ES2067010T3 (fi) |
| FI (1) | FI95264C (fi) |
| HU (1) | HU206120B (fi) |
| IE (1) | IE64984B1 (fi) |
| IL (1) | IL93586A (fi) |
| MX (1) | MX19785A (fi) |
| NO (1) | NO174152C (fi) |
| NZ (1) | NZ232805A (fi) |
| PH (1) | PH26923A (fi) |
| PT (1) | PT93353B (fi) |
| ZA (1) | ZA901742B (fi) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4015715A1 (de) * | 1990-05-16 | 1991-11-21 | Bayer Ag | Neuartige oligophosphate mit antiviraler wirkung |
| IE912115A1 (en) * | 1990-06-25 | 1992-01-01 | Takeda Chemical Industries Ltd | Bisphosphonic acid derivatives, their production and use |
| US5159108A (en) * | 1990-09-18 | 1992-10-27 | Merck & Co., Inc. | Process for preparing an antihypercalcemic agent |
| CA2058012A1 (en) * | 1990-12-19 | 1992-06-20 | Takashi Sohda | Bisphosphonic acid derivatives, their production and use |
| IT1244698B (it) * | 1991-02-01 | 1994-08-08 | Gentili Ist Spa | Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale |
| DK0531253T3 (da) * | 1991-08-27 | 1997-01-27 | Ciba Geigy Ag | N-substituerede aminomethandiphosphonsyrer |
| EP0541037A3 (en) * | 1991-11-06 | 1997-02-26 | Takeda Chemical Industries Ltd | Squalene synthetase inhibitory composition and use thereof |
| US5283057A (en) * | 1992-04-24 | 1994-02-01 | The Procter & Gamble Company | Risedronate in oral compositions |
| JP2006176499A (ja) * | 2004-11-25 | 2006-07-06 | Nippon Seibutsu Seizai:Kk | 眼疾患治療剤 |
| FR2926081B1 (fr) * | 2008-01-03 | 2010-02-19 | Univ Nantes | Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux |
| FR2973378B1 (fr) * | 2011-03-28 | 2013-10-04 | Atlanthera | Derives d'acide hydroxybisphosphonique bifonctionnels |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3203308A1 (de) * | 1982-01-27 | 1983-07-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate |
| FR2531088B1 (fr) * | 1982-07-29 | 1987-08-28 | Sanofi Sa | Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation |
| GB8419489D0 (en) * | 1984-07-31 | 1984-09-05 | Leo Pharm Prod Ltd | Chemical compounds |
| US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
| IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
| IT1187828B (it) * | 1985-05-24 | 1987-12-23 | Gentili Ist Spa | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi |
| ES2039237T3 (es) * | 1986-04-24 | 1993-09-16 | Fujisawa Pharmaceutical Co., Ltd. | Procedimiento para preparar nuevos compuestos de acido difosfonico. |
| DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| GB8618259D0 (en) * | 1986-07-25 | 1986-09-03 | Leo Pharm Prod Ltd | Pharmaceutical compositions |
| US4871720A (en) * | 1986-11-21 | 1989-10-03 | Ciba-Geigy Corporation | Aromatically substituted azacycloalkyl-alkanediphosphonic acids useful for the treatment of illnesses that can be attributed to calcium metabolism disorders |
| US4933472A (en) * | 1988-04-08 | 1990-06-12 | Yamanouchi Pharmaceutical Co., Ltd. | Substituted aminomethylenebis(phosphonic acid) derivatives |
-
1990
- 1990-02-14 PH PH40050A patent/PH26923A/en unknown
- 1990-02-16 US US07/481,482 patent/US5036058A/en not_active Expired - Fee Related
- 1990-02-16 AU AU49884/90A patent/AU629298B2/en not_active Ceased
- 1990-02-27 EP EP90810150A patent/EP0387194B1/de not_active Expired - Lifetime
- 1990-02-27 AT AT90810150T patent/ATE117308T1/de not_active IP Right Cessation
- 1990-02-27 DE DE59008275T patent/DE59008275D1/de not_active Expired - Fee Related
- 1990-02-27 DK DK90810150.4T patent/DK0387194T3/da active
- 1990-02-27 ES ES90810150T patent/ES2067010T3/es not_active Expired - Lifetime
- 1990-03-01 IL IL9358690A patent/IL93586A/en not_active IP Right Cessation
- 1990-03-05 FI FI901103A patent/FI95264C/fi not_active IP Right Cessation
- 1990-03-06 NZ NZ232805A patent/NZ232805A/en unknown
- 1990-03-06 CA CA002011586A patent/CA2011586A1/en not_active Abandoned
- 1990-03-06 DD DD90338447A patent/DD297824A5/de unknown
- 1990-03-06 PT PT93353A patent/PT93353B/pt not_active IP Right Cessation
- 1990-03-06 MX MX19785A patent/MX19785A/es unknown
- 1990-03-06 KR KR1019900002896A patent/KR900014413A/ko not_active Application Discontinuation
- 1990-03-07 HU HU901348A patent/HU206120B/hu not_active IP Right Cessation
- 1990-03-07 IE IE80990A patent/IE64984B1/en not_active IP Right Cessation
- 1990-03-07 NO NO901077A patent/NO174152C/no unknown
- 1990-03-07 ZA ZA901742A patent/ZA901742B/xx unknown
- 1990-03-08 JP JP2055163A patent/JPH02279689A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0387194B1 (de) | 1995-01-18 |
| NO174152C (no) | 1994-03-23 |
| JPH02279689A (ja) | 1990-11-15 |
| FI95264B (fi) | 1995-09-29 |
| HUT53112A (en) | 1990-09-28 |
| NO901077D0 (no) | 1990-03-07 |
| PT93353A (pt) | 1990-11-07 |
| MX19785A (es) | 1994-03-31 |
| HU901348D0 (en) | 1990-05-28 |
| DK0387194T3 (da) | 1995-03-20 |
| KR900014413A (ko) | 1990-10-23 |
| FI95264C (fi) | 1996-01-10 |
| NO901077L (no) | 1990-09-10 |
| PT93353B (pt) | 1996-02-29 |
| AU629298B2 (en) | 1992-10-01 |
| ES2067010T3 (es) | 1995-03-16 |
| US5036058A (en) | 1991-07-30 |
| ATE117308T1 (de) | 1995-02-15 |
| IL93586A (en) | 1995-06-29 |
| AU4988490A (en) | 1990-09-13 |
| IE64984B1 (en) | 1995-09-20 |
| IL93586A0 (en) | 1990-12-23 |
| IE900809L (en) | 1990-09-08 |
| DD297824A5 (de) | 1992-01-23 |
| HU206120B (en) | 1992-08-28 |
| PH26923A (en) | 1992-12-03 |
| NO174152B (no) | 1993-12-13 |
| DE59008275D1 (de) | 1995-03-02 |
| CA2011586A1 (en) | 1990-09-08 |
| ZA901742B (en) | 1990-10-31 |
| EP0387194A1 (de) | 1990-09-12 |
| NZ232805A (en) | 1992-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT47529A (en) | Process for producing polyethyleneglycol-carbaminates and diagnostic and pharmaceutical compositions comprising such compounds | |
| FI901103A0 (fi) | Menetelmä N-substituoitujen aminoalkaanidifosfonihappojen valmistamiseksi | |
| PT99134A (pt) | Processo para a preparacao de derivados da piperazina | |
| TW198039B (fi) | ||
| GB1322639A (en) | Indoline derivatives and a process for the manufacture thereof | |
| ES8303279A1 (es) | "procedimiento para preparar nuevos derivados de acidos fenil-alifatico-carboxilicos". | |
| YU47723B (sh) | Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina | |
| DE3060236D1 (en) | Thiazole derivatives, their preparation and medicaments containing them | |
| EP0309261A3 (en) | Butenoic acid amides, their salts, pharmaceutical compositions containing them and process for preparing same | |
| HUT47897A (en) | Process for producing salicilates and pharmaceutical compositions containing them | |
| FI884177A (fi) | Foerfarande foer framstaellning av l-aminsyror. | |
| SE7714526L (sv) | Sett att framstella 2-amino-cyklopent-1-en-1-tiokarbonyl-disulfider |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| PC | Transfer of assignment of patent |
Owner name: NOVARTIS AG |
|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: NOVARTIS AG |